Xylose

Xylose

SCHEMBL32665828

COc1ccccc1C(=O)O.O=C[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.49
HPGD P15428 6/20 0.46
KDM4E B2RXH2 5/20 0.46
HSD17B10 Q99714 3/20 0.46
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
CYP2C9 P11712 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CTSD P07339 1/20 0.42
ALDH1A1 P00352 5/20 0.41
ESR1 P03372 1/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
HMGB1 P09429 1/20 0.41
TSHR P16473 1/20 0.41
GGT1 P19440 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
BLM P54132 1/20 0.41
NAPRT Q6XQN6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xylose SCHEMBL21468587 1.00 HTT (0.49) HTTHPGDKDM4EHSD17B10NPC1
Aspirin SCHEMBL2174051 0.84 KDM4E (0.58) HTTHPGDKDM4EHSD17B10CYP2C9
Aspirin SCHEMBL27691894 0.84 KDM4E (0.58) HTTHPGDKDM4EHSD17B10CYP2C9
Phthalic Acid SCHEMBL23567081 0.82 ALDH1A1 (0.45) HPGDKDM4EALDH1A1HMGB1NAPRT
Phthalic Acid SCHEMBL30930043 0.82 ALDH1A1 (0.45) HPGDKDM4EALDH1A1HMGB1NAPRT
Anthranilic Acid SCHEMBL27914571 0.80 MAPT (0.41) HPGDKDM4EHSD17B10NPC1RAB9A
Alcohol SCHEMBL17255935 0.78 HTT (0.70) HTTHPGDKDM4EHSD17B10NPC1
Xylose SCHEMBL29915202 0.77 ALDH1A1 (0.44) HTTHPGDKDM4EHSD17B10NPC1
Demannose SCHEMBL25326591 0.77 CLCN2 (0.40) HTTKDM4ECYP2C9ALDH1A1TSHR
Xylose SCHEMBL31303135 0.77 TSHR (0.47) HPGDKDM4EALDH1A1TSHRNAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12537071-B1 Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins BERMUDES DAVID GORDON (US) 2026-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12537071-B1 Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins ANTXR2, BCOR, ZFX HTT 1769/4885HPGD 743/4885KDM4E 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.